C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $582,324 | -12.1% | 313,077 | +29.9% | 0.00% | – |
| Q2 2023 | $662,858 | -28.2% | 241,039 | -18.1% | 0.00% | – |
| Q1 2023 | $923,594 | -58.7% | 294,138 | -22.4% | 0.00% | – |
| Q4 2022 | $2,237,275 | -25.9% | 379,199 | +10.1% | 0.00% | – |
| Q3 2022 | $3,019,000 | -12.1% | 344,387 | -24.4% | 0.00% | – |
| Q2 2022 | $3,434,000 | -78.5% | 455,456 | -30.7% | 0.00% | -100.0% |
| Q1 2022 | $15,954,000 | -46.1% | 657,572 | -28.4% | 0.00% | -50.0% |
| Q4 2021 | $29,575,000 | +128.2% | 918,470 | +216.6% | 0.00% | +100.0% |
| Q3 2021 | $12,961,000 | +24.0% | 290,096 | +5.0% | 0.00% | +100.0% |
| Q2 2021 | $10,451,000 | +1233.0% | 276,188 | +1203.1% | 0.00% | – |
| Q1 2021 | $784,000 | +159.6% | 21,195 | +132.7% | 0.00% | – |
| Q4 2020 | $302,000 | – | 9,108 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
| Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
| Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
| RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
| WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
| HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
| Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
| Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |